FOX6 News Milwaukee on MSN43m
FDA approves Spravato, nasal spray derived from KetamineThe FDA approves Spravato, a nasal spray derived from Ketamine, to help some people treat depression. Dr. Bill Hartman from UW Health shares more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback